Yatharth Hospital & Trauma Care Services Ltd. Share Price

Overview

Yatharth Hospital & Trauma Care Services Ltd. share price is currently ₹970.42, down by - ₹11.63 (1.18%) from its previous closing price of ₹982.05. The share price has gained 1.83% over the past month and gained 30.17% over the past year. The stock's 52-week low and high are ₹534.70 and ₹1,167.61, respectively. Yatharth Hospital & Trauma Care Services Ltd. has a market capitalisation of ₹ 9,850.00 Cr. The share price was last updated on 14 Oct 2026, 03:54 PM IST.

Yatharth Hospital & Trauma Care Services Ltd.
Yatharth Hospital & Trauma Care Services Ltd.
YATHARTH
 ₹0.00
- ₹11.63
1.18%
Healthcare
 ₹0.00(%)1D

Updated: 14 Oct 2026, 03:54:32 pm IST

Market Data

Open Price

 ₹968.75

Prev. Close

 ₹982.05
 ₹963.22

Day Low

 ₹981.66

Day High

 ₹534.70

52 Week Low

 ₹1,167.61

52 Week High

HealthcareHospital & Healthcare Services
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

51.62

Sector PE

42.81

PB Ratio

5.25

Sector PB

5.66

EPS

18.80

Dividend Yield

0.00

Today's Volume

484.293 K

5 Day Avg. Volume

402.173 K

PEG Ratio

1.50

Market Cap.

₹ 9,850.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsInterim Dividend of 5% at ₹0.5/Share
14-Aug-202614-Aug-2026

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
Bandhan Small Cap Fund - Regular Plan - Growth40.00 Lac
37.63 Lac
(5.92%)
Kotak Multi Cap Fund - Regular Plan - Growth31.53 Lac
31.53 Lac
no change
Kotak Balanced Advantage Fund - Regular Plan - Growth11.05 Lac
11.05 Lac
no change
Groww Multicap Fund - Regular Plan - Growth3.22 Lac
3.22 Lac
no change
Kotak Special Opportunities Fund - Regular Plan - Growth3.10 Lac
3.10 Lac
no change

About Yatharth Hospital & Trauma Care Services Ltd. 👋

Yatharth Hospital & Trauma Care Services Limited is engaged in providing healthcare services, operating hospitals and other allied services. Its facilities include amenities, guidelines for admission, visitor policy, helpdesk, empanelment's, and preventive health checkup. It provides a spectrum of specialty services in the fields of Cardiology, Neurosciences, Pediatrics, Gastroenterology, Pulmonology, Robotic Surgery, Dermatology, Endocrinology, Dentistry, Radiology, Ophthalmology, Cancer & Bone Marrow Transplant, Nephrology & Urology, General Surgery, Psychology & Psychiatry, Plastic & Cosmetic Surgery, Vitro Fertilization (IVF) & Fertility, and Interventional Spine & Pain Medicine. It also provides Nuclear Medicine, Pathology & Laboratory Medicine, Nutrition & Health, Physiotherapy & Rehab, Emergency Medicine, and more. It has hospitals in Greater Noida, Noida, Noida Extension, Jhansi Orchha, and Faridabad. It also has a super-specialty hospital located in Model Town, New Delhi.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Hruthik N

Hruthik N

30 Sep • 11:13 PM · SEBI-Registered Analyst

Kotak Bank Leads as Healthcare Stocks Crash

The market closed lower today, with the Nifty50 down 95.75 points (0.42%) to 22,620.45, and the Sensex slipping 48.78 points (0.07%) to 72,480.29, a volatile session that pared early gains, extending the losing streak for a third straight day. FII outflows (₹10,148 crore net selling) and rising US bond yields added to the pressure. 1)

KOTAKBANK
was today's top gainer, rising 2.71% to close at ₹417.00, with banking broadly providing the market's main support. 2)InterGlobe Aviation (IndiGo) and ICICI Bank rounded out the top gainers, up 2.30% and 2.28% respectively, followed by UltraTech Cement (+1.17%) and Axis Bank (+1.15%), a clearly bank-and-cyclical-led list. 3)Healthcare stocks were hit hard on regulatory concerns. Apollo Hospitals fell 5.70%, dragging the Nifty50 the most, while Max Healthcare, Fortis, and Yatharth Hospital all slumped up to 7% on worries about a proposed price cap on private hospital room rents. 4)Sector performance was genuinely mixed, with 6 of 10 sector indices closing higher, Nifty Realty led with a 1.62% gain, while Nifty Pharma lagged, down 1.84%. Market breadth stayed weak, with only 17-18 of the Nifty50's 50 stocks advancing against 31-32 declining, so despite a few strong gainers, more stocks fell than rose. 5)Broader markets outpaced the Nifty, with midcaps up slightly and smallcaps gaining 0.27%, led by names like Cupid (+8.23%, near its 52-week high) and Aegis Logistics (+6.17%).

See More
DEEPAK PAL

DEEPAK PAL

30 Sep • 2:19 PM · SEBI-Registered Analyst

Hospital Stocks CRASH! Supreme Court Questions ON!

HOSPITAL RISK-->“Sarkari Hospital Mein Jaan Ka Risk… Private Hospital Mein Jameen-Jaydaad Ka Risk!” erns over steep mark-ups on medicines sold through private hospitals. Stocks including

APOLLOHOSP
, Max Healthcare, Fortis Healthcare, Yatharth Hospital, Medanta and Aster DM came under pressure, with several names falling sharply during the session. --->What Did the Supreme Court Question? The Supreme Court was hearing petitions related to medicine pricing, generic prescriptions and medical-device pricing under the Drugs (Prices Control) Order, 2013. During the hearing, the bench highlighted a striking example: A cancer medicine supplied to retailers for around ₹2,700 was cited as carrying an MRP of around ₹27,000. The Court questioned how such a large gap could exist and also raised concerns about hospitals requiring patients to purchase medicines through their own or designated pharmacies. ---->Why Are Hospital Stocks Falling? The market is worried about one simple issue: Medicine mark-ups can be an important part of hospital economics. If hospitals are eventually required to operate with significantly lower medicine margins, it could potentially affect: • Pharmacy-related revenue • EBITDA margins • Profitability • Revenue per patient ---->The 16% Rule — Don't Misunderstand It This is where the headlines can become misleading. The Supreme Court questioned whether a uniform 16% margin could be applied more broadly. But: The Court has NOT ordered a universal 16% cap on all medicines. The existing 16% retailer-margin concept is already used in parts of India's drug-price-control framework for scheduled formulations. ---->Bottom Line Hospital stocks are falling because the Supreme Court has put hospital medicine mark-ups and captive pharmacy practices under the regulatory spotlight. The market is currently pricing in the risk of tighter regulation, not a confirmed 16% margin cap.

See More
Saurabh Tyagi--Clovek,Advisory

Saurabh Tyagi--Clovek,Advisory

20 Sep • 9:18 PM · SEBI-Registered Analyst

Rs 3,150 Cr. Investment Poised to Fuel Yatharth's Growth

YATHARTH
has entered into a definitive agreement with global private-equity firm Advent International, which will invest ₹3,150 crore of primary capital for a 24.9% stake in the company. The transaction, subject to customary closing conditions, represents one of the larger primary private-equity investments in India’s hospital sector. The most important aspect of the transaction is that the entire investment is primary capital, meaning the funds will flow into Yatharth Hospitals rather than being used for an exit by existing shareholders. This provides the company with additional financial resources to expand its hospital network, add capacity and strengthen its medical ***** currently operates nine multi-speciality hospitals with around 2,800 operational beds, with announced capacity of approximately 3,250 beds. Its network spans key markets in North India, including the NCR region, along with Jhansi-Orchha and a growing presence in Agra.

See More
Vivek kumar

Vivek kumar

18 Sep • 5:36 PM · SEBI-Registered Analyst

Yatharth Hospital breaks into price discovery!! watch

Yatharth Hospital breaks into price discovery Yatharth Hospital & Trauma Care Services Limited (NSE: YATHARTH) moved to a fresh 52-week high of ₹1,184 on September 18, 2026, extending its rally after Advent International agreed to invest ₹3,150 crore for a 24.9% stake. The stock opened at ₹1,131.20 after closing at ₹1,072.40 on September 17. By early afternoon, it was around ₹1,132, with the day's range between ₹1,082.40 and ₹1,184. Trading volume was around 48.9 lakh shares. The technical structure has changed quickly. YATHARTH has moved into price discovery after breaking above its previous high. The September 17 announcement had already pushed the stock sharply higher, and the follow-through buying on September 18 confirms that the event is still driving price action. My view is that ₹1,180 to ₹1,185 is the key zone now. A sustained close above this area would keep the breakout structure intact. I would not chase the stock simply because it is making new highs. After a two-day surge, a pullback can also be sharp. For the next setup, I am watching ₹1,130 first. If the stock holds this area after the opening move, the breakout can remain constructive. Below that, ₹1,080 to ₹1,100 becomes the next zone to watch. A decisive move below the recent breakout area would weaken the short-term setup.

See More
Vivek kumar

Vivek kumar

17 Sep • 10:14 PM · SEBI-Registered Analyst

this stock is at 52 week high with good volumes!!

Resistance ₹1,083–₹1,085 — current record-high zone Above ₹1,085, traders may watch for continuation of price discovery. Support ₹1,060–₹1,070 — immediate technical zone ₹1,000–₹1,020 — important previous breakout/consolidation area ₹950–₹980 — deeper support zone based on recent September trading A decisive move above the ₹1,083–₹1,085 zone with strong volume would be technically significant. Conversely, a rejection followed by a move below ₹1,060 could indicate short-term profit booking. Advent International's proposed ₹3,150 crore investment is the major catalyst. The transaction is expected to give Advent a 24.9% stake, while the Tyagi family is expected to remain the largest shareholder. The company currently operates nine multi-speciality hospitals with approximately 2,800 operational beds, with announced capacity expected to rise to about 3,250 beds. For a technical trader, the key thing to watch now is whether Yatharth can sustain prices above the ₹1,083–₹1,085 record-high zone rather than simply touching it intraday. A failed breakout could bring profit-booking toward the nearby support zones. This is technical analysis, not a personalized buy/sell recommendation. The stock is currently reacting to a major corporate event, so volatility can remain elevated.

See More
Finkhoz Roboadvisory Services

Finkhoz Roboadvisory Services

17 Sep • 1:22 PM · SEBI-Registered Analyst

Advent’s ₹3,150 crore bet puts Yatharth in focus

YATHARTH
Hospital shares rose around 7% on September 17 after the company announced that private equity firm Advent International will invest ₹3,150 crore for a 24.9% stake. The investment will be through primary capital and remains subject to customary closing conditions. The deal provides Yatharth with significant fresh capital to support its next phase of expansion. The company operates hospitals across North India and has expanded its network to more than 2,800 beds, including its recently acquired Gurugram hospital. Advent’s investment also brings a global healthcare investor with experience in India’s hospital sector, which could support expansion and operational capabilities. For investors, the key potential catalysts are inorganic expansion, higher hospital capacity and improved scale, while the primary infusion avoids the immediate overhang associated with promoter stake dilution through a secondary sale. The Tyagi family will remain the largest shareholder after the transaction. However, investors should monitor the transaction’s completion, deployment of funds, acquisition execution, hospital occupancy, margins and return on invested capital. Rapid expansion can also increase execution and integration risks. Overall, the Advent investment is a major capital-raising event for Yatharth, with future earnings growth depending on how effectively the fresh capital is deployed.

See More

News & Events

Frequently Asked Questions

What is the share price of Yatharth Hospital & Trauma Care Services Ltd.?

What is the market cap of Yatharth Hospital & Trauma Care Services Ltd.?

Should I buy Yatharth Hospital & Trauma Care Services Ltd. stock now?

What is the 52 week high and low of Yatharth Hospital & Trauma Care Services Ltd.?

Is the Yatharth Hospital & Trauma Care Services Ltd. stock good to buy?

Is Yatharth Hospital & Trauma Care Services Ltd. a good buy for the long term?

Is Yatharth Hospital & Trauma Care Services Ltd. overvalued or undervalued?

What is the PE and PB ratio of Yatharth Hospital & Trauma Care Services Ltd.?

Start Now